tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sumant Kulkarni, 202 are a BUY (89.78%), 22 are a HOLD (9.78%), 1 are a SELL (0.44%).
Analyst Sumant Kulkarni, currently employed at CANACCORD, carries an average stock price target met ratio of 33.59% that have a potential upside of 37.77% achieved within 270 days.
Sumant Kulkarni’s has documented 430 price targets and ratings displayed on 28 stocks. The coverage is on Healthcare, Industrials, Technology sectors.
Most recent stock forecast was given on ANVS, Annovis Bio at 18-Aug-2026.
Analyst best performing recommendations are on CARA (CARA THERAPEUTIC).
The best stock recommendation documented was for CARA (CARA THERAPEUTIC) at 6/13/2024. The price target of $10 was fulfilled within 4 days with a profit of $5.97 (37.38%) receiving and performance score of 93.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 06-Mar-2025
$28
$-2.57 (-8.41%)
Buy Since 20-Oct-2025
$40
$9.43 (30.85%)
$39
Buy Since 24-Sep-2025
$38
$7.43 (24.30%)
$29
Buy Since 16-Oct-2023
$49
$18.43 (60.29%)
$40
Buy Since 27-Feb-2024
$41
$10.43 (34.12%)
$29
Which stock is Sumant Kulkarni is most bullish on?
Which stock is Sumant Kulkarni is most reserved on?
What Year was the first public recommendation made by Sumant Kulkarni?
